Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCS.L Regulatory News (SCS)

  • There is currently no data for SCS

INTERIM DIVIDEND AND BOARD UPDATE

6 Apr 2020 07:00

RNS Number : 8083I
ScS Group PLC
06 April 2020
 

For immediate release

6 April 2020

 

 

 

ScS Group plc

("ScS" or the "Group")

 

INTERIM DIVIDEND AND BOARD UPDATE

 

The Group announced on 24 March 2020, that it had temporarily closed its stores, distribution network and head office in order to protect our people and our customers. Whilst stores remain closed, ScS has continued to provide support to our customers and employees through dedicated teams, who we have enabled to work remotely.

 

Financial position & interim dividend

 

The Group continues to review all ongoing cash expenditure to protect our liquidity in the short term. The business has moved in a swift but considered way with regards to furloughing an appropriate number of our colleagues, whilst, at the same time, maintaining customer support. We continue to monitor and utilise any further Government support that is available.

 

Our focus in recent years on building a business with increasing resilience is reflected in the strength of our balance sheet and the level of flexibility in our cost base. We cannot predict the impact of COVID-19 but we believe the Group is as well positioned as it can be.

 

Despite the strength of our balance sheet, the Board feels that it is appropriate to suspend payment of the interim dividend, which was due to be paid on 7 May 2020. At a time when the UK Government is supporting ScS, it seems inappropriate to use the cash for anything other than protecting the financial strength and resilience of the business.

 

The Board recognises the importance of income to the Group's shareholders and will continue to assess when it is appropriate to recommence dividend payments. 

 

Board update

 

As announced on 29 January 2020, David Knight notified the Board of his intention to retire as Group CEO. He had given 12 months' notice in accordance with his contract. Given current circumstances, the Board and David have agreed that he will not retire before the end of July 2021. David is prepared to be flexible should the appointment of his successor and a smooth handover require a little longer. The Board is very grateful to David for his flexibility regarding his retirement date.

 

 

Enquiries:

 

ScS Group PLC

David Knight, Chief Executive Officer

Chris Muir, Chief Financial Officer

c/o Buchanan +44 (0)20 7466 5000

 

 

Buchanan

Richard Oldworth

Tilly Abraham

Charlotte Slater

Tel: +44 (0)20 7466 5000

scs@buchanan.uk.com

 

Notes to editors

ScS is one of the UK's largest retailers of upholstered furniture and floorings, promoting itself as the "Sofa Carpet Specialist", seeking to offer value and choice through a wide range of upholstered furniture and flooring products. The Group's product range is designed to appeal to a broad customer base with a mid-market priced offering and is currently traded from 100 stores.

 

The Group's upholstered furniture business specialises primarily in fabric and leather sofas and chairs. ScS sells a range of branded products which are not sold under registered trade marks and a range of branded products which are sold under registered trade marks owned by ScS (such as Endurance, Inspire and SiSi Italia). The Group also offers a range of third party brands (which include La-Z-Boy, G Plan and Celebrity). The Company's flooring business includes carpets, as well as laminate and vinyl flooring.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBIGDSCUGDGGX
Date   Source Headline
21st Nov 20074:00 pmRNSResults of Meetings
21st Nov 20072:39 pmRNSNet Asset Value(s)
20th Nov 20073:05 pmRNSNet Asset Value(s)
19th Nov 20074:21 pmRNSNet Asset Value(s)
16th Nov 20074:20 pmRNSNet Asset Value(s)
15th Nov 20074:42 pmRNSNet Asset Value(s)
14th Nov 20074:36 pmRNSNet Asset Value(s)
13th Nov 20074:42 pmRNSNet Asset Value(s)
12th Nov 20076:12 pmRNSNet Asset Value(s)-Amendment
12th Nov 20072:57 pmRNSNet Asset Value(s)
9th Nov 200712:43 pmRNSNet Asset Value(s)
8th Nov 20071:28 pmRNSNet Asset Value(s)
7th Nov 20073:16 pmRNSNet Asset Value(s)
6th Nov 20071:09 pmRNSNet Asset Value(s)
5th Nov 20071:33 pmRNSNet Asset Value(s)
2nd Nov 20071:52 pmRNSNet Asset Value(s)
2nd Nov 200711:47 amRNSPortfolio Update
1st Nov 20072:27 pmRNSNet Asset Value(s)
31st Oct 20071:44 pmRNSNet Asset Value(s)
30th Oct 20074:37 pmRNSNet Asset Value(s)
29th Oct 20073:51 pmRNSNet Asset Value(s)
26th Oct 20073:47 pmRNSNet Asset Value(s)
25th Oct 20075:09 pmRNSNet Asset Value(s)
25th Oct 20074:05 pmRNSRollover Proposals
24th Oct 20075:26 pmRNSDividend Declaration
24th Oct 20074:25 pmRNSNet Asset Value(s)
23rd Oct 20073:38 pmRNSNet Asset Value(s)
22nd Oct 20073:26 pmRNSNet Asset Value(s)
19th Oct 20074:12 pmRNSNet Asset Value(s)
18th Oct 20071:56 pmRNSNet Asset Value(s)
17th Oct 200712:59 pmRNSNet Asset Value(s)
16th Oct 20073:28 pmRNSNet Asset Value(s)
15th Oct 20072:57 pmRNSNet Asset Value(s)
12th Oct 20074:06 pmRNSNet Asset Value(s)
11th Oct 20073:25 pmRNSNet Asset Value(s)
10th Oct 20071:42 pmRNSNet Asset Value(s)
9th Oct 20073:27 pmRNSNet Asset Value(s)
8th Oct 20073:00 pmRNSNet Asset Value(s)
5th Oct 20071:43 pmRNSNet Asset Value(s)
4th Oct 20071:45 pmRNSNet Asset Value(s)
3rd Oct 20071:56 pmRNSNet Asset Value(s)
2nd Oct 20072:31 pmRNSNet Asset Value(s)
1st Oct 20071:15 pmRNSNet Asset Value(s)
28th Sep 200712:08 pmRNSNet Asset Value(s)
27th Sep 20073:11 pmRNSNet Asset Value(s)
26th Sep 200712:26 pmRNSNet Asset Value(s)
25th Sep 200711:48 amRNSNet Asset Value(s)
24th Sep 200712:29 pmRNSNet Asset Value(s)
21st Sep 200712:45 pmRNSNet Asset Value(s)
20th Sep 20073:42 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.